High-Quality Services and Enhanced Technical Capabilities for Special Facilities and Spaces
First written in FY2016. 26 of 31 entries say "Restated". Latest entry: 2026-07-31.
4 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「Amid this economic environment, the building maintenance industry is showing strong interest not only in energy and cost savings, but also in advanced technical capabilities such as operating-room sterilization and nosocomial infection prevention at hospitals, and validation support at pharmaceutical plants and regenerative medicine laboratories.」
The company continues to show interest in areas requiring advanced technical capabilities, including sterilization at hospitals, pharmaceutical plants and regenerative medicine laboratories, prevention of nosocomial infections, and validation support. - FY2025Addition of new initiativesAnnual report
「To further enhance the Group’s ability to create added value, we will accelerate efforts to strengthen our approach to manufacturing plants and other facilities through the solar power generation business, deepen our engagement with pharmaceutical manufacturing facilities and other sites through validation support, develop new customers among pharmaceutical and medical facilities through new spatial decontamination methods, and expand and strengthen our overseas operations.」
In addition to its existing policy targeting specialized facilities, the company has explicitly identified expansion into pharmaceutical and medical facilities using new spatial decontamination methods as a new initiative. - FY2025-H1RestatedAnnual report
「Amid this economic environment, the building maintenance industry is showing strong interest not only in energy and cost savings, but also in advanced technical capabilities such as operating-room sterilization and nosocomial infection prevention at hospitals, and validation support at pharmaceutical plants and regenerative medicine laboratories.」
The company continues to show interest in areas requiring advanced technical capabilities, including sterilization at hospitals, pharmaceutical plants and regenerative medicine laboratories, prevention of nosocomial infections, and validation support. - FY2024-Q3RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The company continues to show interest in areas requiring advanced technical capabilities, including sterilization at hospitals, pharmaceutical plants and regenerative medicine laboratories, prevention of nosocomial infections, and validation support. - FY2024-Q2RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to indicate interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2024-Q1RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to indicate interest in advanced technologies, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2023RestatedAnnual report
「We will continue to focus on strengthening our approach to the pharmaceutical and regenerative-medicine industries and training engineers to provide optimal facility environments, and lay the groundwork for making this a core business in the future.」
The group continues to describe its approach to the pharmaceutical and regenerative-medicine industries, engineer training, and the groundwork for making this a core business in the future. - FY2023-Q3RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to describe interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, along with the increasing focus on reviewing facility maintenance and management costs. - FY2023-Q2RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to describe interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, along with the increasing focus on reviewing facility maintenance and management costs. - FY2023-Q1RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to indicate interest in advanced technologies, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2022AdvancedAnnual report
「With the Pharmaceutical Facilities Management Department at the center of these efforts, we will focus on training engineers to provide optimal facility environments as we strengthen our approach to the pharmaceutical and regenerative-medicine industries, and lay the groundwork for making this a core business in the future.」
For services targeting specialized facilities, the group explicitly stated that it is strengthening its approach to the pharmaceutical and regenerative-medicine industries and training engineers, centered on the Pharmaceutical Facilities Management Department, and laying the groundwork for making this a core business in the future. - FY2022-Q3RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to describe interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, along with the increasing focus on reviewing facility maintenance and management costs. - FY2022-Q2RestatedAnnual report
「Against this economic backdrop, in the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to indicate interest in advanced technologies, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2022-Q1RestatedAnnual report
「In the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to describe interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, along with the increasing focus on reviewing facility maintenance and management costs. - FY2021RestatedAnnual report
「We will continue to provide high-quality services to facilities with specialized environments requiring advanced technical capabilities for maintenance and management, and strengthen our one-stop services by leveraging the strengths of our business model. Our group defines such facilities as hospitals and research facilities, manufacturing plants and similar facilities, and other specialized facilities.」
The group continues to provide high-quality services to facilities with specialized environments, one-stop services, and stronger technical capabilities. The KPI for the fiscal year ending March 2029 specifies a sales ratio of at least 80.0% for these facilities. - FY2021-Q3RestatedAnnual report
「In the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to describe interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, along with the increasing focus on reviewing facility maintenance and management costs. - FY2021-Q2RestatedAnnual report
「In the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to describe interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, along with the increasing focus on reviewing facility maintenance and management costs. - FY2021-Q1RestatedAnnual report
「In the building maintenance industry, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures. At the same time, awareness of the need to review facility maintenance and management costs has increased.」
The group continues to indicate interest in advanced technologies at hospitals, pharmaceutical plants, and regenerative-medicine research institutes, while also noting the increasing focus on reviewing facility maintenance and management costs. - FY2020RestatedAnnual report
「We will continue to provide high-quality services to facilities with specialized environments that require advanced technical capabilities for maintenance and management, and strengthen our one-stop services by leveraging the strengths of our business model.」
The provision of high-quality services to facilities with specialized environments and the strengthening of one-stop services continue to be identified as medium- to long-term issues. - FY2020-Q3RestatedAnnual report
「In the building maintenance industry, awareness of the need to review facility maintenance and management costs remains strong. At the same time, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures.」
The group has reiterated its recognition that interest continues in areas requiring advanced technical capabilities, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2020-Q2RestatedAnnual report
「In the building maintenance industry, awareness of the need to review facility maintenance and management costs remains strong. At the same time, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures.」
The group has reiterated its recognition that interest continues in areas requiring advanced technical capabilities, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2020-Q1RestatedAnnual report
「In the building maintenance industry, awareness of the need to review facility maintenance and management costs remains strong. At the same time, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures.」
The group has reiterated its recognition that interest continues in areas requiring advanced technical capabilities, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2019RestatedAnnual report
「We will continue to provide high-quality services to facilities with specialized environments that require advanced technical capabilities for maintenance and management, and strengthen our one-stop services by leveraging the strengths of our business model.」
The group continues to provide high-quality services to specialized-environment facilities requiring advanced technical capabilities and has newly explicitly stated that it will strengthen its one-stop services. - FY2019-Q3RestatedAnnual report
「In the building maintenance industry, awareness of the need to review facility maintenance and management costs remains strong. At the same time, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures.」
The group continues to recognize demand for areas requiring advanced technical capabilities, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2019-Q2RestatedAnnual report
「In the building maintenance industry, awareness of the need to review facility maintenance and management costs remains strong. At the same time, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures.」
The group continues to recognize demand for areas requiring advanced technical capabilities, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2019-Q1RestatedAnnual report
「In the building maintenance industry, awareness of the need to review facility maintenance and management costs remains strong. At the same time, interest remains high in advanced technical capabilities, including operating-room sterilization and prevention of nosocomial infections in hospitals and validation support at pharmaceutical plants and regenerative-medicine research institutes, in addition to energy- and cost-saving measures.」
The group continues to recognize demand for areas requiring advanced technical capabilities, including sterilization, prevention of nosocomial infections, and validation support at hospitals, pharmaceutical plants, and regenerative-medicine research institutes. - FY2018RaisedAnnual report
「Our group will continue to provide high-quality services to specialized facilities and spaces requiring advanced technical capabilities. We will also increase the proportion of hospitals, research facilities, manufacturing plants, and similar facilities among the facilities under contract, concentrate management resources on further improving our technical capabilities, satisfy existing customers, and acquire new customers.」
In addition to providing high-quality services to specialized facilities and spaces and strengthening technical capabilities, the group has explicitly stated its policy of increasing the proportion of hospitals, research facilities, manufacturing plants, and similar facilities among contracted facilities, thereby specifying its priority areas. - FY2017RestatedAnnual report
「Our group will continue to provide high-quality services to specialized facilities and spaces requiring advanced technical capabilities. To this end, we will concentrate management resources on further improving our technical capabilities, satisfy existing customers, and acquire new customers.」
The provision of high-quality services to specialized facilities and spaces and the concentration of management resources on strengthening technical capabilities have been reiterated as medium-term issues. - FY2016First statedAnnual report
「Our group will continue to provide high-quality services to specialized facilities and spaces requiring advanced technical capabilities. To this end, we will concentrate management resources on further improving our technical capabilities, satisfy existing customers, and acquire new customers.」
The group has stated its intention to focus on specialized fields, including medical facilities and factories, that require advanced technical capabilities.